These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 132149)

  • 41. Abnormal testosterone excretion in men alcoholics.
    Fabre LF; Pasco PJ; Liegel JM; Farmer RW
    Q J Stud Alcohol; 1973 Mar; 34(1):57-63. PubMed ID: 4266777
    [No Abstract]   [Full Text] [Related]  

  • 42. Urinary and plasma androgens in benign breast disease. Possible relation to breast cancer.
    Brennan MJ; Wang DY; Hayward JL; Bulbrook RD; Deshpande N
    Lancet; 1973 May; 1(7812):1076-9. PubMed ID: 4122007
    [No Abstract]   [Full Text] [Related]  

  • 43. [Glucuronic acid, glucuronyltransferase and estrogens in breast cancer and precancer].
    Al'pert AE; Zhandarova LF
    Vopr Onkol; 1978; 24(10):66-70. PubMed ID: 213895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of chorionic gonadotropin on steroid excretion.
    Scurry MT; Bruton J; Barry KG
    Arch Intern Med; 1971 Oct; 128(4):561-5. PubMed ID: 4255780
    [No Abstract]   [Full Text] [Related]  

  • 45. I. URINARY EXCRETION OF NEUTRAL 17-KETOSTEROIDS AND PREGNANDEIOL BY PATIENTS WITH BREAST CANCER AND BENIGN BREAST DISEASE.
    MARMORSTON J; CROWLEY LG; MYERS SM; STERN E; HOPKINS CE
    Am J Obstet Gynecol; 1965 Jun; 92():447-59. PubMed ID: 14305945
    [No Abstract]   [Full Text] [Related]  

  • 46. A longitudinal study of steroid excretion patterns in children during adolescent growth.
    Gupta D
    Steroidologia; 1970; 1(5):267-94. PubMed ID: 4331676
    [No Abstract]   [Full Text] [Related]  

  • 47. Relationship between hormonal cytology and steroid excretion in post-menopausal women.
    de Waard F; Thijssen JH
    J Endocrinol; 1970 Dec; 48(4):xxxvi. PubMed ID: 5489055
    [No Abstract]   [Full Text] [Related]  

  • 48. Urinary excretion of mono- and disulphates of C19 and C21 steroids with reference to the menstrual cycle.
    Jänne O
    Acta Endocrinol (Copenh); 1971 Jun; 67(2):316-30. PubMed ID: 4252857
    [No Abstract]   [Full Text] [Related]  

  • 49. [Urinary 11-deoxy-17-ketosteroids in breast cancer patients considered in relation to the menstrual cycle: ovulatory and non ovulatory].
    Grattarola R
    Tumori; 1967; 53(2):129-39. PubMed ID: 4227798
    [No Abstract]   [Full Text] [Related]  

  • 50. [Concentration of 17-ketosteroids (17-KS) and their fractions in the urine of males of different age with diabetes mellitus].
    Maksimov SV; Demchenko SV
    Probl Endokrinol (Mosk); 1970; 16(6):21-7. PubMed ID: 4255796
    [No Abstract]   [Full Text] [Related]  

  • 51. Circadian variations of urinary 11-deoxy-17-ketosteroids in normal and hirsute women.
    Toccafondi R; Bianchi G; Rolandi E; Madeddu G
    Riv Crit Clin Med; 1970; 70(1):126-34. PubMed ID: 4268050
    [No Abstract]   [Full Text] [Related]  

  • 52. A comparative study of the urinary excretion of glucocorticoids and 11-deoxy-17-ketosteroids in a group of obese women.
    Hendrikx A; Meulepas E; Heyns W; De Moor P
    Ann Endocrinol (Paris); 1974; 35(4):508-20. PubMed ID: 4283406
    [No Abstract]   [Full Text] [Related]  

  • 53. A single method for determination of urine steroids. I. Levels of testosterone, epitestosterone and 17-ketosteroid fractions. II. Specific activities of testosterone, androsterone and etiocholanolone and production rate of testosterone following administration of labelled testosterone.
    Bird CE; Clark AF
    Clin Biochem; 1970 Sep; 3(3):231-44. PubMed ID: 4258599
    [No Abstract]   [Full Text] [Related]  

  • 54. [Urinary excretion of steroid metabolites in patients following myocardial infarct].
    Felt V; Beran I; Erbert Z; Fiserová J
    Cas Lek Cesk; 1967 Nov; 106(47):1276-7. PubMed ID: 5594464
    [No Abstract]   [Full Text] [Related]  

  • 55. A comparison of urinary 17-hydroxycorticosteroid and 11-deoxy-17-oxosteroid excretion in obesity, in thyroid dysfunction and in early breast cancer.
    Sneddon A; Steel JM; Strong JA
    J Endocrinol; 1969 Feb; 43(2):48-9. PubMed ID: 4237784
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comparing metabolic studies following infusion of delta-4-androstene-3,17-dione, testosterone phosphate and dehydroepiandrosterone phosphate].
    Schubert K; Frankenberg G; Bacigalupo G
    Endokrinologie; 1965 Dec; 49(1):1-12. PubMed ID: 4225497
    [No Abstract]   [Full Text] [Related]  

  • 57. Endocrinological findings in young workers exposed to carbon disulphide. 3. Urinary excretion of 3alpha,11-deoxy-17-ketosteroids.
    Cavalleri A; Djurić D; Maugeri U; Branković D; Visconti E
    Med Lav; 1966 Dec; 57(12):755-60. PubMed ID: 5986179
    [No Abstract]   [Full Text] [Related]  

  • 58. [Urinary elimination of 17-ketosteroids, 11-oxy-17-ketosteroids and some pregnane derivatives in aging].
    Antonini FM; D'Alessandro A; Tinti P; Bucalossi A; Mariotti M
    G Gerontol; 1968 Jul; 16(7):629-34. PubMed ID: 5740727
    [No Abstract]   [Full Text] [Related]  

  • 59. Excretion of conjugated 11-deoxy-17-ketosteroids in "essential" hypertension.
    Dey AC; Abbott EC; Rusted IE; Senciall IR
    Can J Biochem; 1972 Dec; 50(12):1273-81. PubMed ID: 4265062
    [No Abstract]   [Full Text] [Related]  

  • 60. Circadian variations of urinary 11-deoxy-17-ketosteroids in normal subjects.
    Toccafondi R; Bianchi G; Rolandi E; Madeddu G
    Ann Endocrinol (Paris); 1970; 31(6):1087-90. PubMed ID: 4251806
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.